COMP <GO>
CTXR vs OPTH // 10Y YIELD & FRED MACRO BETA
Citius Pharmaceuticals Inc. (NASDAQ) VS. Optimi Health Corp. (NASDAQ) • 15-METRIC TALLY: CTXR 2
— OPTH 0
■ METRIC PARITY
LAST: $0.56 (+4.07%) • MKT CAP: $15.5M
macro-sensitivity
—
LAST: $2.60 (-6.81%) • MKT CAP: $14.9M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTXR VS. OPTH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTXR | OPTH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.6 | 18.3 | +35.34 | CTXR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.5M | $14.9M | $571.3K | CTXR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTXR REV | OPTH REV | CTXR GROSS % | OPTH GROSS % | CTXR FCF | OPTH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | — | — | — | -$26.6M | — |
| FY 2024 | $0 | — | — | — | -$28.2M | — |
| FY 2023 | $0 | — | — | — | -$29.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTXR // BETA —
OPTH // BETA —